Nitazoxanide
CAS: 55981-09-4
Ref. 3D-FN26229
10g | 136,00 € | ||
25g | 156,00 € | ||
50g | 217,00 € | ||
100g | 325,00 € | ||
250g | 452,00 € |
Produktinformation
- 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamideo-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenyl acetate
- 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide
- 2-[(5-Nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
- Alinia
- Brn 1225475
- Cryptaz
- Daxon
- Dexidex
- Drg 0242
- Kidonax
- Mehr Synonyme anzeigen
- Mitafar
- N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)
- NTX
- NTZ
- Nitacure
- Nitacure 500
- Nitarid
- Nitazode
- Nitazox 500
- Nitazoxanida
- Nixide
- Nixoran
- Nizonide
- Nsc 697855
- Pacovanton
- ParaMix
- Ph 5776
- Xerovirin-C
- acetate de o-[N-(5-nitrothiazole-2-yl)carbamoyl]phenyle
- acetato de o-[N-(5-nitrotiazol-2-il)carbamoil]fenilo
- o-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenylacetat
- o-[N-(5-nitrothiazol-2-yl)carbamoyl]phenyl acetate
- Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-
Nitazoxanide is a prodrug that is converted to the active form, nitazoxanide triacetate, in the stomach. It inhibits the growth of infectious agents by preventing their synthesis of DNA, RNA, or protein. Nitazoxanide has been shown to be effective against persistent strains of influenza A (H1N1) and A (H3N2) as well as rotavirus. It also has been shown to have a low toxicity profile in human clinical trials. Nitazoxanide is not an anti-inflammatory agent and does not inhibit cyclooxygenase enzymes. The drug can potentially be used for treatment of cancer due to its ability to inhibit mitochondrial membrane potential, which may lead to cell death.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FN26229 Nitazoxanide
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.